Evidence map›Paper›PMID 31164164›Full record

ArticleArthritis research & therapy2019

Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet's disease.

Naomi Tsuchida, Yohei Kirino, Yutaro Soejima, Masafumi Onodera, Katsuhiro Arai, Eiichiro Tamura, Takashi Ishikawa, Toshinao Kawai, Toru Uchiyama, Shigeru Nomura and 9 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Behçet's Disease: A Comprehensive Review on the Role ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. [Haploinsufficiency of A20 in a family caused by a heterozygous deletion in theZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
  6. Article
  7. Behçet-like Syndromes: A Comprehensive Review.Dermatopathology (Basel, Switzerland) · 2026
    Review
  8. Monogenic disorders of the TNF signalling pathway.Nature reviews. Rheumatology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Cellular and molecular basis of proximal small intestine disorders.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Repressive Control of Keratinocyte Cytoplasmic Inflammatory Signaling.International journal of molecular sciences · 2023
    Review
  18. The Expanding Spectrum of Autoinflammatory Diseases.Internal medicine (Tokyo, Japan) · 2023
    Article
  19. Review
  20. Novel loss-of-function mutations inClinical kidney journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Naomi TsuchidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Yohei KirinoDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. kirino@yokohama-cu.ac.jp.ORCID 0000-0002-9488-661X
Yutaro SoejimaDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Masafumi OnoderaDivision of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Katsuhiro AraiDivision of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan.
Eiichiro TamuraDivision of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Takashi IshikawaDivision of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Toshinao KawaiDivision of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Toru UchiyamaDivision of Immunology, National Center for Child Health and Development, Tokyo, Japan.
Shigeru NomuraDepartment of Pediatrics, University of Tokyo Hospital, Tokyo, Japan.
Daisuke KobayashiDivision of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Masataka TaguriDepartment of Data Science, Yokohama City University School of Data Science, Yokohama, Japan.
Satomi MitsuhashiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Atsushi TakataDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Hideaki NakajimaDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. naomat@yokohama-cu.ac.jp.
Yokohama City University · JPNational Center For Child Health and Development · JPNiigata University · JPUniversity of Tokyo Hospital · JPYokohama City University Hospital · JP

Funding

Japan Agency for Medical Research and Development JP18ek0109280, JP18dm0107090, JP18ek0109301, JP18ek0109348, JP18kk020501Japan Society for the Promotion of Science JP16H05357Japan Society for the Promotion of Science JP16H06254Japan Society for the Promotion of Science JP17H01539Japan Society for the Promotion of Science JP17K10080Japan Society for the Promotion of Science JP17K15630Japan Society for the Promotion of Science JP26713036
6 · The paper itself

Abstract

backgroundHaploinsufficiency of A20 (HA20) is caused by loss-of-function TNFAIP3 variants. Phenotypic and genetic features of HA20 remain uncertain; therefore, the clinical distinction between HA20 and Behçet's disease (BD) requires clarification.

methodsWe have collected 12 Japanese BD-like families. Probands of these families were analyzed by whole exome sequencing (WES) and subsequent Sanger sequencing. Clinical features were compared between 54 HA20 patients (including previously reported and new cases) and 520 Japanese BD patients.

resultsWe identified c.1434C>A:p.(Cys478*) in one family and a 236 kb deletion at 6q23.3 containing TNFAIP3 in another family. Four HA20 patients in the two families presented with childhood-onset recurrent oral and genital ulcers and were initially diagnosed and treated as BD. Consistent with the clinical features of HA20, recurrent, refractory fever attacks (three of four patients), and digestive ulcers (two of the four patients) were observed. A comparison of clinical features between HA20 patients and cohorts of BD patients revealed several critical features specific to HA20. These were early-onset, familial occurrence, recurrent fever attacks, gastrointestinal involvement, and infrequent ocular involvement.

conclusionsWe identified a novel nonsense variant and deletion of the entire TNFAIP3 gene in two unrelated Japanese HA20 families. Genetic screening of TNFAIP3 should be considered for familial BD-like patients with early-onset recurrent fevers.

Indexed as

Genetic Predisposition to DiseaseMutationAdultBehcet SyndromeChildDNADNA Mutational AnalysisFemaleGenetic TestingHaploinsufficiencyHumansMalePedigreePhenotypeTumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3DNATNFAIP3 protein, humanTumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3AutoinflammatoryBehçet’s diseaseHaploinsufficiency of A20TNFAIP3Whole exome sequencing

Identifiers

PMID31164164
PMCPMC6549368
OpenAlexW2948184955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.